• Yearly deal numbers fell for the first time, by 18%.
• The total amount invested also fell by 12% from 2015.
• Crowdfunding deals at growth-stage increased 10%, with 80% of these deals being completed by companies crowdfunding for the first time.
• There was no significant drop in deal numbers after the EU referendum, suggesting Brexit has so far had little to no short-term impact on equity investment.
• Investment into early-stage life sciences companies is booming. Seed-stage life sciences businesses saw a 19% increase in deals, and a record £202m invested.
• Wales and Northern Ireland bucked the general trend, seeing a 30% and 8% increase in deal numbers respectively.

Read the full report here